From the group to the individual in schizophrenia spectrum disorders: Biomarkers of social cognitive impairments and therapeutic translation

People with schizophrenia spectrum disorders (SSDs) often experience persistent social cognitive impairments, associated with poor functional outcome. There are currently no approved treatment options for these debilitating symptoms, highlighting the need for novel therapeutic strategies. Work to date has elucidated differential social processes and underlying neural circuitry affected in SSDs, which may be amenable to modulation using neurostimulation. Further, advances in functional connectivity mapping and electric field modeling may be utilized to identify individualized treatment targets to maximize the impact of brain stimulation on social cognitive networks.
Source: Biological Psychiatry - Category: Psychiatry Authors: Tags: Review Source Type: research